Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 17, 2022

View Archived Issues

MAL protein seen to regulate epithelial-mesenchymal transition in gastric cancer

Pyruvate kinase isozyme M2 activators identified at the University of Michigan

Enanta Pharmaceuticals describes SARS-CoV-2 3C-like proteinase inhibitors

Novo Nordisk discovers GIP-R/GLP-1 receptor coagonists

Columbia University patents SERT/VMAT2 inhibitors

Angion Biomedica divulges new ROCK1/ROCK2 inhibitors

Trastuzumab engineered with bone-homing peptides for treating breast cancer metastasis to bone

Novel indole derivative shows potent antileukemia activity in zebrafish xenograft model

Pharmacological IRE1/XBP1s activation mitigates obesity-driven metabolic dysfunction

TRIM13 prevents pathogenic DNA-triggered inflammatory responses

Structure-function analysis of HER2-HER3 dimers in HER2-amplified cancers uncovers new target sites

Alvea's SARS-CoV-2 DNA vaccine Alveavax enters preclinical testing

BioVaxys reports ACE2 binding inhibition data with haptenized SARS-CoV-2 vaccine BVX-0320

Asep advances antibiofilm peptide technology for wound dressings

FDA grants orphan drug designation to HSB-1216 for uveal melanoma

Insilico Medicine nominates preclinical compound in QPCTL program

Intellia and ONK enter licensing and collaboration agreement for allogeneic NK cell therapies

BetterLife reports findings from preclinical neural plasticity study of BETR-001

CROI 2022: Predicting the future to get ahead of viruses

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 19, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...